Patent · US Active

Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones

US11065219B2 · kind B2 · utility

7Cited by
64References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2019
Grant dateJul 20, 2021
Priority date—
Expiry dateApr 5, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.